{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:33:59Z","timestamp":1793723639476,"version":"4.6.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Remnant cholesterol\/high-density lipoprotein cholesterol (RC\/HDL-C) ratio has been shown to be a good predictor of metabolic disease risk, but no studies have further investigated the role of RC\/HDL-C ratio in non-alcoholic fatty liver disease (NAFLD) patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The participants were 14,251 adults who underwent a physical examination, all of whom underwent abdominal ultrasonography to determine whether they had NAFLD. Receiver operating characteristic curve analysis and multivariate logistic regression models were used to assess the association between the RC\/HDL-C ratio and the risk of NAFLD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Multivariate logistic regression analysis showed that after fully adjusting the confounding factors, the higher RC\/HDL-C ratio was independently positively correlated with the risk of NAFLD. Interaction tests suggested that the effect of RC\/HDL-C ratio on NAFLD was significantly affected by sex. Additionally, receiver operating characteristic curve analysis showed that the area under the curve of RC\/HDL-C ratio for identifying NAFLD was 0.82, which was significantly higher than that of other conventional lipid parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study indicates for the first time that the higher RC\/HDL-C ratio in the general population may be closely related to the increased risk of NAFLD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12876-022-02216-x","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T00:40:40Z","timestamp":1648168840000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Remnant cholesterol\/high-density lipoprotein cholesterol ratio is a new powerful tool for identifying non-alcoholic fatty liver disease"],"prefix":"10.1186","volume":"22","author":[{"given":"Yang","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maobin","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliang","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,24]]},"reference":[{"issue":"1","key":"2216_CR1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384.","journal-title":"Hepatology"},{"issue":"3","key":"2216_CR2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","volume":"70","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM. Non-alcoholic fatty liver disease: a global public health perspective. J Hepatol. 2019;70(3):531\u2013544.","journal-title":"J Hepatol"},{"issue":"5","key":"2216_CR3","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3390\/ijms17050774","volume":"17","author":"L Calzadilla Bertot","year":"2016","unstructured":"Calzadilla Bertot L, Adams LA. The natural course of non-alcoholic fatty liver disease. Int J Mol Sci. 2016;17(5):774.","journal-title":"Int J Mol Sci"},{"key":"2216_CR4","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jhep.2014.11.034","volume":"62","author":"S McPherson","year":"2015","unstructured":"McPherson S, Hardy T, Henderson E, Burt AD, Day CP, Anstee QM. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management. J Hepatol. 2015;62:1148\u20131155.","journal-title":"J Hepatol."},{"issue":"8","key":"2216_CR5","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.metabol.2016.01.012","volume":"65","author":"Y Fazel","year":"2016","unstructured":"Fazel Y, Koenig AB, Sayiner M, Goodman ZD, Younossi ZM. Epidemiology and natural history of non-alcoholic fatty liver disease. Metabolism. 2016;65(8):1017\u201325.","journal-title":"Metabolism"},{"issue":"1 Suppl","key":"2216_CR6","first-page":"S47-64","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62(1 Suppl):S47-64.","journal-title":"J Hepatol"},{"issue":"16","key":"2216_CR7","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.4155\/fmc-2019-0003","volume":"11","author":"S Ballestri","year":"2019","unstructured":"Ballestri S, Mantovani A, Nascimbeni F, Lugari S, Lonardo A. Extra-hepatic manifestations and complications of nonalcoholic fatty liver disease. Future Med Chem. 2019;11(16):2171\u20132192.","journal-title":"Future Med Chem"},{"issue":"6","key":"2216_CR8","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","volume":"66","author":"LA Adams","year":"2017","unstructured":"Adams LA, Anstee QM, Tilg H, Targher G. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut. 2017;66(6):1138\u20131153.","journal-title":"Gut"},{"issue":"8","key":"2216_CR9","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.metabol.2016.05.003","volume":"65","author":"N Katsiki","year":"2016","unstructured":"Katsiki N, Mikhailidis DP, Mantzoros CS. Non-alcoholic fatty liver disease and dyslipidemia: an update. Metabolism. 2016;65(8):1109\u201323.","journal-title":"Metabolism"},{"issue":"7","key":"2216_CR10","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.cgh.2013.08.014","volume":"12","author":"KE Corey","year":"2014","unstructured":"Corey KE, Chalasani N. Management of dyslipidemia as a cardiovascular risk factor in individuals with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2014;12(7):1077\u201384.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"2216_CR11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12944-021-01457-1","volume":"20","author":"Y Zou","year":"2021","unstructured":"Zou Y, Zhong L, Hu C, Zhong M, Peng N, Sheng G. LDL\/HDL cholesterol ratio is associated with new-onset NAFLD in Chinese non-obese people with normal lipids: a 5-year longitudinal cohort study. Lipids Health Dis. 2021;20(1):28.","journal-title":"Lipids Health Dis"},{"issue":"4","key":"2216_CR12","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MOL.0000000000000429","volume":"28","author":"A Varbo","year":"2017","unstructured":"Varbo A, Nordestgaard BG. Remnant lipoproteins. Curr Opin Lipidol. 2017;28(4):300\u2013307.","journal-title":"Curr Opin Lipidol"},{"issue":"3","key":"2216_CR13","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/MOL.0000000000000682","volume":"31","author":"CAA Salinas","year":"2020","unstructured":"Salinas CAA, Chapman MJ. Remnant lipoproteins: are they equal to or more atherogenic than LDL? Curr Opin Lipidol. 2020;31(3):132\u2013139.","journal-title":"Curr Opin Lipidol"},{"issue":"3","key":"2216_CR14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.5551\/jat.E598","volume":"16","author":"Y Fujioka","year":"2009","unstructured":"Fujioka Y, Ishikawa Y. Remnant lipoproteins as strong key particles to atherogenesis. J Atheroscler Thromb. 2009;16(3):145\u201354.","journal-title":"J Atheroscler Thromb"},{"issue":"4","key":"2216_CR15","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jacc.2012.08.1026","volume":"61","author":"A Varbo","year":"2013","unstructured":"Varbo A, Benn M, Tybj\u00e6rg-Hansen A, J\u00f8rgensen AB, Frikke-Schmidt R, Nordestgaard BG. Remnant cholesterol as a causal risk factor for ischemic heart disease. J Am Coll Cardiol. 2013;61(4):427\u2013436.","journal-title":"J Am Coll Cardiol"},{"key":"2216_CR16","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.atherosclerosis.2019.08.014","volume":"290","author":"Authors\/Task Force Members","year":"2019","unstructured":"Authors\/Task Force Members, ESC Committee for Practice Guidelines (CPG), ESC National Cardiac Societies. 2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Atherosclerosis. 2019;290:140\u2013205.","journal-title":"Atherosclerosis"},{"issue":"1","key":"2216_CR17","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12933-020-01076-7","volume":"19","author":"YX Cao","year":"2020","unstructured":"Cao YX, Zhang HW, Jin JL, et al. The longitudinal association of remnant cholesterol with cardiovascular outcomes in patients with diabetes and pre-diabetes. Cardiovasc Diabetol. 2020;19(1):104.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2216_CR18","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12944-021-01490-0","volume":"20","author":"K Li","year":"2021","unstructured":"Li K, Fan F, Zheng B, et al. Associations between remnant lipoprotein cholesterol and central systolic blood pressure in a Chinese community-based population: a cross-sectional study. Lipids Health Dis. 2021;20(1):60.","journal-title":"Lipids Health Dis"},{"issue":"6","key":"2216_CR19","doi-asserted-by":"crossref","first-page":"100150","DOI":"10.1016\/j.jhepr.2020.100150","volume":"2","author":"J Chin","year":"2020","unstructured":"Chin J, Mori TA, Adams LA, et al. Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents. JHEP Rep. 2020;2(6):100150.","journal-title":"JHEP Rep"},{"issue":"11","key":"2216_CR20","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3390\/jcm7110378","volume":"7","author":"D Pastori","year":"2018","unstructured":"Pastori D, Baratta F, Novo M, Cocomello N, Violi F, Angelico F, Del Ben M. Remnant lipoprotein cholesterol and cardiovascular and cerebrovascular events in patients with non-alcoholic fatty liver disease. J Clin Med. 2018;7(11):378.","journal-title":"J Clin Med"},{"issue":"2","key":"2216_CR21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jjcc.2016.12.010","volume":"70","author":"RX Zeng","year":"2017","unstructured":"Zeng RX, Li S, Zhang MZ, et al. Remnant cholesterol predicts periprocedural myocardial injury following percutaneous coronary intervention in poorly-controlled type 2 diabetes. J Cardiol. 2017;70(2):113\u2013120.","journal-title":"J Cardiol"},{"issue":"1","key":"2216_CR22","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12944-020-01336-1","volume":"19","author":"WS Yang","year":"2020","unstructured":"Yang WS, Li R, Shen YQ, et al. Importance of lipid ratios for predicting intracranial atherosclerotic stenosis. Lipids Health Dis. 2020;19(1):160.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"2216_CR23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41366-018-0076-3","volume":"43","author":"T Okamura","year":"2019","unstructured":"Okamura T, Hashimoto Y, Hamaguchi M, Obora A, Kojima T, Fukui M. Ectopic fat obesity presents the greatest risk for incident type 2 diabetes: a population-based longitudinal study. Int J Obes (Lond). 2019;43(1):139\u2013148.","journal-title":"Int J Obes (Lond)"},{"key":"2216_CR24","doi-asserted-by":"publisher","DOI":"10.5061\/dryad.8q0p192","volume-title":"Data from: Ectopic fat obesity presents the greatest risk for incident type 2 diabetes: a population-based longitudinal study","author":"Takuro Okamura","year":"2019","unstructured":"Okamura, Takuro et al. (2019), Data from: Ectopic fat obesity presents the greatest risk for incident type 2 diabetes: a population-based longitudinal study, Dryad, Dataset, https:\/\/doi.org\/10.5061\/dryad.8q0p192."},{"issue":"4","key":"2216_CR25","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3350\/cmh.2020.0163","volume":"26","author":"JH Choi","year":"2020","unstructured":"Choi JH, Sohn W, Cho YK. The effect of moderate alcohol drinking in nonalcoholic fatty liver disease. Clin Mol Hepatol. 2020;26(4):662\u2013669.","journal-title":"Clin Mol Hepatol"},{"key":"2216_CR26","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1111\/j.1572-0241.2007.01526.x","volume":"102","author":"M Hamaguchi","year":"2007","unstructured":"Hamaguchi M, Kojima T, Itoh Y, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol Am J Gastroenterol. 2007;102:2708\u201315.","journal-title":"Am J Gastroenterol Am J Gastroenterol"},{"key":"2216_CR27","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0140-6736(14)61177-6","volume":"384","author":"BG Nordestgaard","year":"2014","unstructured":"Nordestgaard BG, Varbo A. Triglycerides and cardiovascular disease. Lancet. 2014;384:626\u2013635.","journal-title":"Lancet"},{"key":"2216_CR28","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1476-511X-9-52","volume":"9","author":"Y Chen","year":"2010","unstructured":"Chen Y, Zhang X, Pan B, et al. A modified formula for calculating low-density lipoprotein cholesterol values. Lipids Health Dis. 2010;9:52.","journal-title":"Lipids Health Dis"},{"key":"2216_CR29","first-page":"e202-e213","volume":"16","author":"EJA Fitchett","year":"2016","unstructured":"Fitchett EJA, Seale AC, Vergnano S, et al. Strengthening the reporting of observational studies in epidemiology for newborn infection (STROBE-NI): an extension of the STROBE statement for neonatal infection research. Lancet Infect Dis. 2016;16:e202-e213.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"2216_CR30","doi-asserted-by":"crossref","first-page":"558","DOI":"10.4097\/kja.19087","volume":"72","author":"JH Kim","year":"2019","unstructured":"Kim JH. Multicollinearity and misleading statistical results. Korean J Anesthesiol. 2019;72(6):558\u2013569.","journal-title":"Korean J Anesthesiol"},{"key":"2216_CR31","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.ijsu.2014.07.014","volume":"12","author":"JP Vandenbroucke","year":"2014","unstructured":"Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Int J Surg. 2014;12:1500\u20131524.","journal-title":"Int J Surg"},{"issue":"3","key":"2216_CR32","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837\u201345.","journal-title":"Biometrics"},{"issue":"10","key":"2216_CR33","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrcardio.2013.132","volume":"10","author":"BM Mearns","year":"2013","unstructured":"Mearns BM. Dyslipidaemia: Role of remnant cholesterol in IHD. Nat Rev Cardiol. 2013;10(10):553.","journal-title":"Nat Rev Cardiol"},{"issue":"5","key":"2216_CR34","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/ATVBAHA.116.308834","volume":"37","author":"SJ Bernelot Moens","year":"2017","unstructured":"Bernelot Moens SJ, Verweij SL, Schnitzler JG, et al. Remnant cholesterol elicits arterial wall inflammation and a multilevel cellular immune response in humans. Arterioscler Thromb Vasc Biol. 2017;37(5):969\u2013975.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"2216_CR35","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2174\/138945009787846434","volume":"10","author":"BG Nordestgaard","year":"2009","unstructured":"Nordestgaard BG, Langsted A, Freiberg JJ. Nonfasting hyperlipidemia and cardiovascular disease. Curr Drug Targets. 2009;10(4):328\u201335.","journal-title":"Curr Drug Targets"},{"issue":"9","key":"2216_CR36","doi-asserted-by":"crossref","first-page":"4547","DOI":"10.3390\/ijms22094547","volume":"22","author":"EW Kjeldsen","year":"2021","unstructured":"Kjeldsen EW, Nordestgaard LT, Frikke-Schmidt R. HDL cholesterol and non-cardiovascular disease: a narrative review. Int J Mol Sci. 2021;22(9):4547.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2216_CR37","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1053\/hj.1998.v136.89586","volume":"136","author":"H Masuoka","year":"1998","unstructured":"Masuoka H, Ishikura K, Kamei S, et al. Predictive value of remnant-like particles cholesterol\/high-density lipoprotein cholesterol ratio as a new indicator of coronary artery disease. Am Heart J. 1998;136(2):226\u201330.","journal-title":"Am Heart J"},{"issue":"9","key":"2216_CR38","first-page":"1037","volume":"8","author":"E Turola","year":"2015","unstructured":"Turola E, Petta S, Vanni E, et al. Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis. Dis Model Mech. 2015;8(9):1037\u201346.","journal-title":"Dis Model Mech"},{"issue":"4","key":"2216_CR39","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00125-003-1074-z","volume":"46","author":"M Cnop","year":"2003","unstructured":"Cnop M, Havel PJ, Utzschneider KM, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia. 2003;46(4):459\u201369.","journal-title":"Diabetologia"},{"key":"2216_CR40","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.maturitas.2021.06.012","volume":"151","author":"R Robeva","year":"2021","unstructured":"Robeva R, Mladenovi\u0107 D, Veskovi\u0107 M, et al. The interplay between metabolic dysregulations and non-alcoholic fatty liver disease in women after menopause. Maturitas. 2021;151:22\u201330.","journal-title":"Maturitas"},{"issue":"1","key":"2216_CR41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41574-020-00431-8","volume":"17","author":"GH Goossens","year":"2021","unstructured":"Goossens GH, Jocken JWE, Blaak EE. Sexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liver. Nat Rev Endocrinol. 2021;17(1):47\u201366.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"2216_CR42","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12944-019-1123-3","volume":"18","author":"WC Yeh","year":"2019","unstructured":"Yeh WC, Tsao YC, Li WC, Tzeng IS, Chen LS, Chen JY. Elevated triglyceride-to-HDL cholesterol ratio is an indicator for insulin resistance in middle-aged and elderly Taiwanese population: a cross-sectional study. Lipids Health Dis. 2019;18(1):176.","journal-title":"Lipids Health Dis"},{"issue":"8","key":"2216_CR43","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.2337\/dc10-2234","volume":"34","author":"C Giannini","year":"2011","unstructured":"Giannini C, Santoro N, Caprio S, et al. The triglyceride-to-HDL cholesterol ratio: association with insulin resistance in obese youths of different ethnic backgrounds. Diabetes Care. 2011;34(8):1869\u201374.","journal-title":"Diabetes Care"},{"issue":"1","key":"2216_CR44","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0021-9150(02)00057-6","volume":"164","author":"H Ohnishi","year":"2002","unstructured":"Ohnishi H, Saitoh S, Takagi S, et al. Relationship between insulin-resistance and remnant-like particle cholesterol. Atherosclerosis. 2002;164(1):167\u201370.","journal-title":"Atherosclerosis"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-022-02216-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-022-02216-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-022-02216-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T09:28:02Z","timestamp":1648200482000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-022-02216-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,24]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2216"],"URL":"https:\/\/doi.org\/10.1186\/s12876-022-02216-x","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,24]]},"assertion":[{"value":"15 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As the previous study had been authorized by the ethics committee of Murakami Memorial Hospital, the Institutional Review Board of this study exempted the application for duplicate ethical authorization (IRB Number: 2021-066).  We confirm that all the methods used in this study were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"134"}}